-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
C4 Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q4 2024.
- C4 Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$37.7M, a 0.75% decline year-over-year.
- C4 Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$120M, a 14% increase year-over-year.
- C4 Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$120M, a 14% increase from 2023.
- C4 Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$139M, a 7.33% decline from 2022.
- C4 Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$130M, a 57.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)